Get the Stockscreener App
24.39
1.30%
-0.32
Pre-market:
24.99
0.60
+2.46%
Doximity Inc stock is traded at $24.39, with a volume of 3.70M.
It is down -1.30% in the last 24 hours and down -0.08% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$24.71
Open:
$23.5
24h Volume:
3.70M
Relative Volume:
1.06
Market Cap:
$4.51B
Revenue:
$637.78M
Net Income/Loss:
$239.40M
P/E Ratio:
20.48
EPS:
1.1909
Net Cash Flow:
$307.21M
1W Performance:
+7.63%
1M Performance:
-0.08%
6M Performance:
-64.13%
1Y Performance:
-54.16%
1-Day Range:
$23.05
$24.50
1-Week Range:
$21.98
$25.65
52-Week Range:
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.39 | 4.51B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
168.84 | 27.58B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
56.78 | 10.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
47.81 | 9.24B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
86.33 | 7.29B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
26.71 | 5.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (DOCS) falls more steeply than broader market: What investors need to know - MSN
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
BofA Cuts PT on Doximity, Inc. (DOCS) to $47 From $56 - Insider Monkey
Doximity (NYSE:DOCS) Shares Gap DownTime to Sell? - MarketBeat
Doximity stock holds Strong Buy at Raymond James after CFO exit - Investing.com
Leerink raises Doximity stock price target to $34 on valuation By Investing.com - Investing.com South Africa
Doximity (DOCS) Faces Downgrade and Adjusted Growth Outlook - GuruFocus
This Qorvo Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $29 - Moomoo
Robinhood To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Doximity Inc. (NYSE:DOCS): A GARP Stock With Strong Growth and a Reasonable Price - ChartMill
Doximity, Inc. (DOCS) Stock Analysis: Assessing a 54.89% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Analyst recommendations: Doximity, Okta, Bloom Energy, Intel, Whirlpool… - marketscreener.com
Doximity, Inc. (NYSE:DOCS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Truist cuts Doximity stock rating on softer growth outlook By Investing.com - Investing.com Australia
Truist cuts Doximity stock rating on softer growth outlook - Investing.com
Doximity CFO resigns; interim finance head continues - MSN
Truist Financial Downgrades Doximity(DOCS.US) to Hold Rating, Announces Target Price $29 - Moomoo
Doximity Stock Hits Day High with Strong 7.42% Intraday Surge - Markets Mojo
Doximity, Inc. Stock Plummets to New 52-Week Low of $20.55 - Markets Mojo
Doximity, Inc. Files Form 8-K Announcing Executive Leadership Changes and Corporate Updates April 2026 - Minichart
Doximity: Priced Like SaaS, Built Like Advertising (NYSE:DOCS) - Seeking Alpha
Doximity announces CFO resignation and reaffirms quarterly guidance By Investing.com - Investing.com Australia
Doximity announces CFO resignation and reaffirms quarterly guidance - Investing.com
Doximity CFO Resigns After Medical Leave - Moomoo
Doximity | 8-K: Current report - Moomoo
CFO exits Doximity (NYSE: DOCS) as company keeps full-year guidance - Stock Titan
Is Doximity (DOCS) one of the stocks set to explode in the next 3 years? - MSN
DOCS Maintained by B of A Securities -- Price Target Lowered to $47 - GuruFocus
Doximity Is Maintained at Buy by B of A Securities - Moomoo
Doximity (NYSE:DOCS) Given New $47.00 Price Target at Bank of America - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Call Transcript - MSN
BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $47 - Moomoo
GitLab, Twilio, and Doximity Shares Skyrocket, What You Need To Know - Yahoo Finance
BofA cuts Doximity stock price target on transition year outlook By Investing.com - Investing.com South Africa
BofA cuts Doximity stock price target on transition year outlook - Investing.com
Why Doximity Activity Is Turning Heads in Healthcare Tech? - Kalkine Media
Doximity Insider Sells $51,000 in Shares - National Today
Insider Selling: Doximity (NYSE:DOCS) Insider Sells 2,427 Shares of Stock - MarketBeat
Doximity interim PFO Sitaram sold $51k in DOCS stock By Investing.com - Investing.com South Africa
AI Disruption Jitters and Insider Sales Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity interim PFO Sitaram sold $51k in DOCS stock - Investing.com
Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Doximity (NYSE: DOCS) interim PFO sells shares to cover option taxes - Stock Titan
Here is Why Doximity (DOCS) Still Appears Attractive - Insider Monkey
Can Doximity (DOCS) Turn Its Physician-Focused AI Ecosystem Into Durable Financial Strength? - Yahoo Finance
Is Doximity (NYSE:DOCS) Gaining Traction on The Russell 1000 Index? - Kalkine Media
DOCS Maintained by Keybanc -- Price Target Lowered to $30 - GuruFocus
Assessing Doximity (DOCS) Valuation After Soft Guidance And Rising AI Competition Concerns - Yahoo Finance
KeyCorp Issues Pessimistic Forecast for Doximity (NYSE:DOCS) Stock Price - MarketBeat
Doximity (DOCS) Slid on Concerns Over AI Disruption - Insider Monkey
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
4.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):